The elevated frequency of dual IGH::MYC and IGH::BCL2 fusions in the Asian group (4.9% of the cohort had HGBCL) suggests an enrichment of double-hit lymphomas, potentially contributing to the worse outcomes reported in this population [13]. The gene discussed is MYC; the disease is lymphoma.